Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05065866
Title Duvelisib in Combination With CC-486 in Lymphoid Malignancy
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors H. Lee Moffitt Cancer Center and Research Institute
Indications

diffuse large B-cell lymphoma

aggressive NK-cell leukemia

mantle cell lymphoma

lymphoma

adult T-cell leukemia/lymphoma

prolymphocytic leukemia

B-cell lymphoma

primary mediastinal B-cell lymphoma

Therapies

Azacitidine + Duvelisib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.